Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Xylazine (CAS 7361-61-7)

0.0(0)
Write a reviewAsk a question

See product citations (9)

Application:
Xylazine is an α2 class of adrenergic receptor agonist
CAS Number:
7361-61-7
Molecular Weight:
220.33
Molecular Formula:
C12H16N2S
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Xylazine is a compound that has garnered attention in the field of veterinary research due to its properties as an alpha-2 adrenergic receptor agonist. It is extensively used in studies that investigate its mechanisms of action. Research on xylazine often involves exploring its kinetics in various species to understand how it is absorbed, distributed, metabolized, and excreted. Additionally, xylazine is used in the development of animal handling protocols that aim to minimize stress and improve animal welfare during procedures that require immobilization. The compound′s effects on cardiovascular and respiratory systems are also a key area of study.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences


Xylazine (CAS 7361-61-7) References

  1. Cardiovascular effects of medetomidine, detomidine and xylazine in horses.  |  Yamashita, K., et al. 2000. J Vet Med Sci. 62: 1025-32. PMID: 11073071
  2. Severe intoxication from xylazine inhalation.  |  Capraro, AJ., et al. 2001. Pediatr Emerg Care. 17: 447-8. PMID: 11753193
  3. A comparison of the sedative effects of three alpha 2-adrenoceptor agonists (romifidine, detomidine and xylazine) in the horse.  |  England, GC., et al. 1992. J Vet Pharmacol Ther. 15: 194-201. PMID: 1359161
  4. [Old and new alpha 2-adrenoceptor agonists. 1. Xylazine and medetomidine].  |  Schmidt-Oechtering, GU. and Becker, K. 1992. Tierarztl Prax. 20: 447-58. PMID: 1359676
  5. Cardiovascular effects of xylazine and detomidine in horses.  |  Wagner, AE., et al. 1991. Am J Vet Res. 52: 651-7. PMID: 1854087
  6. A comparison of ketamine/xylazine and ketamine/xylazine/acepromazine anesthesia in the rabbit.  |  Lipman, NS., et al. 1990. Lab Anim Sci. 40: 395-8. PMID: 2166867
  7. Xylazine--a review of its pharmacology and use in veterinary medicine.  |  Greene, SA. and Thurmon, JC. 1988. J Vet Pharmacol Ther. 11: 295-313. PMID: 3062194
  8. Xylazine for sedation of horses.  |  Holmes, AM. and Clark, WT. 1977. N Z Vet J. 25: 159-61. PMID: 351482
  9. Comparative analgesia of xylazine, xylazine/morphine, xylazine/butorphanol, and xylazine/nalbuphine in the horse, using dental dolorimetry.  |  Brunson, DB. and Majors, LJ. 1987. Am J Vet Res. 48: 1087-91. PMID: 3631691
  10. Acute reversible cataract induced by xylazine and by ketamine-xylazine anesthesia in rats and mice.  |  Calderone, L., et al. 1986. Exp Eye Res. 42: 331-7. PMID: 3754819
  11. Xylazine and xylazine-ketamine in dogs.  |  Haskins, SC., et al. 1986. Am J Vet Res. 47: 636-41. PMID: 3963565
  12. Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses.  |  Muir, WW., et al. 1977. Am J Vet Res. 38: 195-201. PMID: 842917
  13. Effect of xylazine, detomidine, and a combination of xylazine and butorphanol on equine duodenal motility.  |  Merritt, AM., et al. 1998. Am J Vet Res. 59: 619-23. PMID: 9582967
  14. The regulatory status of xylazine for use in food-producing animals in the United States.  |  Chamberlain, PL. and Brynes, SD. 1998. J Vet Pharmacol Ther. 21: 322-9. PMID: 9731956

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Xylazine, 1 g

sc-253838
1 g
$65.00